Cardiovascular outcomes in patients with atrial fibrillation concomitantly treated with antiarrhythmic drugs and non-vitamin k antagonist oral anticoagulants

VCC Wu, CL Wang, YC Huang, HT Tu, YT Huang… - Europace, 2023 - academic.oup.com
Aims Limited data compared antiarrhythmic drugs (AADs) with concomitant non-vitamin K
antagonist oral anticoagulants in atrial fibrillation patients, hence the aim of the study …

[HTML][HTML] Cardiovascular outcomes in patients with atrial fibrillation concomitantly treated with antiarrhythmic drugs and non-vitamin k antagonist oral anticoagulants

VCC Wu, CL Wang, YC Huang, HT Tu, YT Huang… - Europace, 2023 - ncbi.nlm.nih.gov
Aims Limited data compared antiarrhythmic drugs (AADs) with concomitant non-vitamin K
antagonist oral anticoagulants in atrial fibrillation patients, hence the aim of the study …

[PDF][PDF] Cardiovascular outcomes in patients with atrial fibrillation concomitantly treated with antiarrhythmic drugs and non-vitamin k antagonist oral anticoagulants

VCC Wu, CL Wang, YC Huang, HT Tu, YT Huang… - 2023 - researchgate.net
Cardiovascular outcomes in patients with atrial fibrillation concomitantly treated with
antiarrhythmic drugs and non-vitamin ka Page 1 …

Cardiovascular outcomes in patients with atrial fibrillation concomitantly treated with antiarrhythmic drugs and non-vitamin k antagonist oral anticoagulants.

VC Wu, CL Wang, YC Huang, HT Tu… - … : Journal of the …, 2023 - europepmc.org
Aims Limited data compared antiarrhythmic drugs (AADs) with concomitant non-vitamin K
antagonist oral anticoagulants in atrial fibrillation patients, hence the aim of the study …

Cardiovascular outcomes in patients with atrial fibrillation concomitantly treated with antiarrhythmic drugs and non-vitamin k antagonist oral anticoagulants

VCC Wu, CL Wang, YC Huang, HT Tu, YT Huang… - Europace, 2023 - pure.lib.cgu.edu.tw
AIMS: Limited data compared antiarrhythmic drugs (AADs) with concomitant non-vitamin K
antagonist oral anticoagulants in atrial fibrillation patients, hence the aim of the study …

Cardiovascular outcomes in patients with atrial fibrillation concomitantly treated with antiarrhythmic drugs and non-vitamin k antagonist oral anticoagulants

VCC Wu, CL Wang, YC Huang… - … : journal of the …, 2023 - pubmed.ncbi.nlm.nih.gov
Aims Limited data compared antiarrhythmic drugs (AADs) with concomitant non-vitamin K
antagonist oral anticoagulants in atrial fibrillation patients, hence the aim of the study …

[PDF][PDF] Cardiovascular outcomes in patients with atrial fibrillation concomitantly treated with antiarrhythmic drugs and non-vitamin k antagonist oral anticoagulants

VCC Wu, CL Wang, YC Huang, HT Tu, YT Huang… - Europace, 2023 - academic.oup.com
Aims Limited data compared antiarrhythmic drugs (AADs) with concomitant non-vitamin K
antagonist oral anticoagulants in atrial fibrillation patients, hence the aim of the study …

Cardiovascular outcomes in patients with atrial fibrillation concomitantly treated with antiarrhythmic drugs and non-vitamin k antagonist oral anticoagulants

VCC Wu, CL Wang, YC Huang, HT Tu, YT Huang… - Europace, 2023 - pure.lib.cgu.edu.tw
AIMS: Limited data compared antiarrhythmic drugs (AADs) with concomitant non-vitamin K
antagonist oral anticoagulants in atrial fibrillation patients, hence the aim of the study …